Publication
Response to omalizumab in urticaria asthma Is it ‘a life‐time together’ treatment?
Bildiri
Google Scholar
Atıf kopyala
P. A. BAÇÇIOĞLU, & P. A. F. KALPAKLIOĞLU (n.d.). Response to omalizumab in urticaria asthma Is it ‘a life‐time together’ treatment?. *European Academy of Allergy and Clinical Immunology Congress, 26–30 May 2018, Munich, Germany*, 29.
Yayın bilgileri
Dergi
European Academy of Allergy and Clinical Immunology Congress, 26–30 May 2018, Munich, Germany
Veri tabanı
Google Scholar
Sayfa
29 – -
Atıf verisi 14 Kasım 2026 tarihinde güncellendi.
Etkinlik: European Academy of Allergy and Clinical Immunology Congress, 26–30 May 2018, Munich, Germany | Yıl: 01.08.2018 | Yazarlar: KALPAKLIOĞLU AYŞE FÜSUN,BAÇÇIOĞLU AYŞE,CERİT AHU
Citations by source
| Kaynak | Atıf |
|---|---|
| Google Scholar | 0 |
| Etkin | 0 |
Yayın metrikleri (GS / WoS / Scopus)
GS
0
Google Scholar Atıf
Co-authorship network among authors
Collaboration links among KKU authors of this publication.
Loading co-author network...
No co-author data
Not enough KKU author records for this publication.
Shared publications
Other publications by authors
Other academic outputs by the same KKU authors — newest first.
İlgili yayınlar yükleniyor…
İlgili yayın bulunamadı.
